No Data
No Data
Disa Increases Share Capital Through Exercise of Options
Disa (SGX:532) disclosed an increase of SG$800,000 in its issued and paid-up share capital, raising it to SG$59.7 million from SG$58.9 million, according to a Singapore bourse filing on Thursday. This
Disa Unit to Deploy AI-Based Eye Care Solutions at MSG Hospitals
Disa (SGX:532) announced today that its unit, Digital Life Line (DLL), has signed a memorandum of understanding with Medical Saigon Group (MSG) to trial the deployment of its automated visual acuity t
DISA Subsidiary Starts Trial Deployment of Vision Screening Tech in Vietnam
DISA's (SGX:532) subsidiary, Digital Life Line, started a trial deployment of its Automated Visual Acuity Test Device (AVAT) in collaboration with Eye Hospital Social Enterprise Company in Vietnam, ac
DISA's Subsidiary Signs MoU for Trial Deployment of Ophthalmology Solution
DISA's (SGX:532) subsidiary, DLL, signed a memorandum of understanding with Vietnam-based Alina Eye Hospital for the trial deployment of its AI-powered ophthalmology solution, AVAT, according to a fil
Disa Unit Completes Trial Rollout of Eye Screening Device at Singapore Public Hospital; Shares Balloon 100%
Digital Life Line, a subsidiary of Disa's (SGX:532) wholly-owned DiSa Digital Safety, completed the first trial rollout of a medical device for eye screening in a major public hospital in Singapore, a
DISA Shrinks Loss in Fiscal First Half
DISA (SGX:532) saw a 38.2% decline in attributable loss for the six months ended Dec. 31, 2023, to SG$686,000 from SG$1.1 million during the year-ago period. Loss per share remained consistent at SG$0
No Data